Seaweed supplement to prevent fatigue during chemo
Part of Cancer, Digestive system clinical trials.
This trial tests whether a natural supplement called fucoidan (from seaweed) can help prevent the fatigue often caused by chemotherapy. It is for people with gastrointestinal or gynecologic cancer starting a platinum-based treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are starting a specific type of chemotherapy (platinum-based doublet or triplet) for GI or gynecologic cancer that is not meant to cure the cancer
- You have not used chemotherapy or immunotherapy in the last 90 days
- You are not currently taking any drugs or supplements meant to boost energy or treat fatigue, like ginseng or antidepressants for fatigue
- You are not on blood thinners like warfarin, heparin, or similar, and do not have a bleeding disorder
- You are willing to take the study supplement and fill out questionnaires about how you feel
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called mifomelatide (TCMCB07) to see if it can help people with newly diagnosed colorectal or pancreatic cancer maintain a healthy weight while receiving certain types of chemotherapy. You would give yourself a daily injection under the skin.
This study tests whether a seaweed-based supplement called fucoidan can help reduce fatigue in cancer survivors. You take a daily capsule and fill out questionnaires about your energy levels.
This study tests whether a supplement made from seaweed (fucoidan) can help reduce gut inflammation in people with mild to moderate ulcerative colitis. If you join, you'll take the supplement and have your symptoms and blood levels checked.
This trial tests whether a specific nutrition supplement (amino acids and flavonoids) can lessen chemotherapy side effects, support nutrition, and improve quality of life in people with non-metastatic breast cancer. It focuses on women who are receiving certain chemotherapy medicines and can eat by mouth and attend regular visits.
This trial studies whether a carefully planned “fasting-mimicking” diet can be safely added to chemotherapy for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. It may help improve how the body handles treatment, but you must meet specific nutrition and cancer-response criteria.
This study tests an oral supplement (Nuvastatic) to see if it helps reduce fatigue in people with stage IV colon cancer who are starting chemotherapy for the first time. If you are 18–65 and have fatigue that is affecting you, this trial might offer a way to feel better.
Hear when a new Malignant Digestive System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.